Concord Biotech Announces 1:1 Bonus Issue; Record Date Set for November 4, 2026

Concord Biotech Limited has announced a 1:1 bonus issue, under which eligible shareholders will receive one additional fully paid-up equity share of ₹10 for every one share held. The company has fixed November 4, 2026, as the record date for determining shareholder eligibility.

The announcement was made through an exchange notice dated October 30, 2026, under Corporate Actions.
 

Key Details

What Does the 1:1 Bonus Issue Mean for Shareholders?
Under the announced 1:1 bonus ratio, shareholders will receive one additional equity share for every existing share held.

For example:

- If you hold 10 shares, you will receive 10 additional shares.
- If you hold 50 shares, you will receive 50 additional shares.
- If you hold 100 shares, you will receive 100 additional shares.
 

The number of shares in your demat account will double, while the share price will theoretically adjust proportionately after the bonus issue. The bonus issue itself does not increase the overall value of your investment.
Important Note on Share Allotment
 

According to the exchange announcement, the company has informed that 10,46,16,204 equity shares would be allotted as on November 5, 2026, as per its letter dated October 29, 2026.

Investors should refer to the company's official communication for confirmation of the allotment details.